Cambrian Bioworks Bags $ 1.45 Mn in Funding

Share via:


SUMMARY

Cambrian Bioworks raised $1.45 million in seed funding led by the Irani family office to improve its automated molecular diagnostics platforms and expand globally.

Founded in 2020, the Bengaluru-based startup develops automated platforms used in oncology, genomics, and disease testing.

With the recent launch of Manta, their nucleic acid extraction device, Cambrian Bioworks plans to extend its reach by enabling broader access to automated devices for liquid biopsy testing,

Biotechnology startup Cambrian Bioworks has secured $1.45 Mn (INR 12 Cr) in a seed funding round led by the Irani family office, along with participation from the company’s cofounder and CEO Vaibhav Hegde.

The Bengaluru-based startup plans to use the fresh capital to scale up its automated molecular diagnostics platforms, bolster R&D efforts, expand team and support international market expansion.

Founded in 2020, by Vaibhav Hegde, Rohit Asil and Raghav Sridhar, Cambrian Bioworks builds automated molecular diagnostic platforms. 

The company’s products find applications in oncology, genomics, rare disease testing, and AMR detection. It builds tools for advanced DNA sequencing and molecular diagnostic markets. 

“Molecular diagnostics is crucial for precise diagnosis, disease subtyping, and therapy selection in cancer care. This funding marks a significant milestone in our journey.” Hegde said. 

(The story will be updated soon)





Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Cambrian Bioworks Bags $ 1.45 Mn in Funding


SUMMARY

Cambrian Bioworks raised $1.45 million in seed funding led by the Irani family office to improve its automated molecular diagnostics platforms and expand globally.

Founded in 2020, the Bengaluru-based startup develops automated platforms used in oncology, genomics, and disease testing.

With the recent launch of Manta, their nucleic acid extraction device, Cambrian Bioworks plans to extend its reach by enabling broader access to automated devices for liquid biopsy testing,

Biotechnology startup Cambrian Bioworks has secured $1.45 Mn (INR 12 Cr) in a seed funding round led by the Irani family office, along with participation from the company’s cofounder and CEO Vaibhav Hegde.

The Bengaluru-based startup plans to use the fresh capital to scale up its automated molecular diagnostics platforms, bolster R&D efforts, expand team and support international market expansion.

Founded in 2020, by Vaibhav Hegde, Rohit Asil and Raghav Sridhar, Cambrian Bioworks builds automated molecular diagnostic platforms. 

The company’s products find applications in oncology, genomics, rare disease testing, and AMR detection. It builds tools for advanced DNA sequencing and molecular diagnostic markets. 

“Molecular diagnostics is crucial for precise diagnosis, disease subtyping, and therapy selection in cancer care. This funding marks a significant milestone in our journey.” Hegde said. 

(The story will be updated soon)





Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

a16z’s Brian Quintenz top pick for CFTC chair under...

Former CFTC commissioner Brian Quintenz, now a16z’s policy...

Xiaohongshu expects over $1b profits in 2024

The Chinese social media and ecommerce platform is...

Australia fines Kraken’s operator $5.1m for regulatory breaches

Australia took legal action against the company for...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!